Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-23T09:53:03.884Z Has data issue: false hasContentIssue false

Chapter 74 - Gynaecological Cancers and Pregnancy

from Section 9 - Co-Morbidities during Pregnancy

Published online by Cambridge University Press:  20 November 2021

Tahir Mahmood
Affiliation:
Victoria Hospital, Kirkcaldy
Charles Savona Ventura
Affiliation:
University of Malta, Malta
Ioannis Messinis
Affiliation:
University of Thessaly, Greece
Sambit Mukhopadhyay
Affiliation:
Norfolk & Norwich University Hospital, UK
Get access

Summary

There are few epidemiological studies on cancer in pregnancy, as national registries usually do not combine data on both cancer diagnosis and obstetrics. Nationwide linkage studies estimated the incidence of pregnancy-associated cancer, defined as a cancer diagnosis during pregnancy or within 12 months from delivery, to be 1 in 1000–2000 pregnancies [1]. The difference in estimated incidence between studies is explained by the difference in denominator used (live births, births beyond 20 weeks or pregnancies). The distribution of the various cancer types diagnosed in pregnancy is similar to that in the non-pregnant premenopausal population. Gynaecological cancers are one of the most common oncological diagnoses during pregnancy, after breast cancer, melanoma and haematological cancers [2]. Figure 74.1 represents the distribution of patients with a diagnosis during pregnancy in the registry of the international network on Cancer, Infertility and Pregnancy (www.cancerinpregnancy.org). Melanoma is probably underrepresented in this registry, as these patients are mostly diagnosed in the early stage and often not referred to centres that participate in the registration study.

Type
Chapter
Information
The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
Obstetrics & Maternal-Fetal Medicine
, pp. 602 - 611
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Smith, LH, Danielsen, B, Allen, ME, Cress, R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003 Oct;189(4):1128–35.Google Scholar
de Haan, J, Verheecke, M, Van Calsteren, K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–46.Google Scholar
Han, SN, Lotgerink, A, Gziri, MM, et al. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med. 2012 Aug 8;10:86.Google Scholar
Timmerman, D, Van Calster, B, Testa, A, et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol. 2016 Apr;214(4):424–37.CrossRefGoogle ScholarPubMed
Dauer, LT, Thornton, RH, Miller, DL, et al. Radiation management for interventions using fluoroscopic or computed tomographic guidance during pregnancy: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe with Endorsement by the Canadian Interventional Radiology Association. J Vasc Interv Radiol. 2012 Jan;23(1):1932.CrossRefGoogle ScholarPubMed
Han, SN, Amant, F, Michielsen, K et al. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study. Eur Radiol. 2018 May;28(5):1862–74.CrossRefGoogle ScholarPubMed
Ray, JG, Vermeulen, MJ, Bharatha, A, Montanera, WJ, Park, AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016 Sep 6;316(9):952–61.CrossRefGoogle ScholarPubMed
Committee on Obstetric Practice. Guidelines for Diagnostic Imaging during Pregnancy and Lactation, ACOG Committee Opinion No 723. October 2017.Google Scholar
Han, SN, Amant, F, Cardonick, EH, et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. Breast Cancer Res Treat. 2018;168(2):551–7.CrossRefGoogle ScholarPubMed
Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014 Mar;24(3):394403.Google Scholar
Amant, F, Berveiller, P, Boere, I, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601–12.Google Scholar
Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk, Green-top Guideline No 37a. London: Royal College of Obstetricians and Gynaecologists, 13 April 2015.Google Scholar
Berveiller, P, Marty, O, Vialard, F, Mir, O. Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer. Expert Opin Drug Metab Toxicol. 2016 May;12(5):523–31.Google Scholar
Calsteren, KV, Verbesselt, R, Devlieger, R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010 Dec;20(9):1456–64.Google Scholar
van Hasselt, JG, van Calsteren, K, Heyns, L, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol. 2014 Oct;25(10):2059–65.Google Scholar
Amant, F, von Minckwitz, G, Han, SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013 Jul 10;31(20):2532–9.Google Scholar
Zagouri, F, Sergentanis, TN, Chrysikos, D, Filipits, M, Bartsch, R. Taxanes for ovarian cancer during pregnancy: a systematic review. Oncology. 2012;83(4):234–8.CrossRefGoogle ScholarPubMed
Zagouri, F, Sergentanis, TN, Chrysikos, D, Bartsch, R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013 Feb;121(2 Pt 1):337–43.Google Scholar
Geijteman, EC, Wensveen, CW, Duvekot, JJ, van Zuylen, L. A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol. 2014 Aug;124(2Pt 2 Suppl 1):454–6.CrossRefGoogle ScholarPubMed
Amant, F, Van Calsteren, K, Halaska, MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012 Mar;13(3):256–64.CrossRefGoogle ScholarPubMed
Amant, F, Vandenbroucke, T, Verheecke, M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015 Nov 5;373(19):1824–34.Google Scholar
Pentheroudakis, G, Pavlidis, N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006 Jan;42(2):126–40.Google Scholar
Morice, P, Uzan, C, Gouy, S, Verschraegen, C, Haie-Meder, C. Gynaecological cancers in pregnancy. Lancet. 2012 Feb 11;379(9815):558–69.CrossRefGoogle ScholarPubMed
Zanotti-Fregonara, P, Chastan, M, Edet-Sanson, A, et al. New fetal dose estimates from 18F-FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms. J Nucl Med. 2016 Nov;57(11):1760–3.CrossRefGoogle ScholarPubMed
Stensheim, H, Moller, B, van Dijk, T, Fossa, SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009 Jan 1;27(1):4551.Google Scholar
Halaska, MJ, Uzan, C, Han, SN, et al. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy. Int J Gynecol Cancer. 2019 Mar 20;ijgc-2018-000103.Google Scholar
Xia, T, Gao, Y, Wu, B, Yang, Y. Clinical analysis of twenty cases of cervical cancer associated with pregnancy. J Cancer Res Clin Oncol. 2015 Sep;141(9):1633–7.Google Scholar
Fruscio, R, de Haan, J, Van Calsteren, K, et al. Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:108–17.Google Scholar
Gui, T, Cao, D, Shen, K, et al. Management and outcome of ovarian malignancy complicating pregnancy: an analysis of 41 cases and review of the literature. Clin Transl Oncol. 2013 Jul;15(7):548–54.Google Scholar
Nazer, A, Czuzoj-Shulman, N, Oddy, L, Abenhaim, HA. Incidence of maternal and neonatal outcomes in pregnancies complicated by ovarian masses. Arch Gynecol Obstet. 2015 Nov;292(5):1069–74.Google Scholar
Cardonick, E, Usmani, A, Ghaffar, S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010 Jun;33(3):221–8.Google Scholar
Peccatori, FA, Azim, HA Jr, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24(Suppl 6):vi160–70.Google Scholar
Blake, EA, Kodama, M, Yunokawa, M, et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:97105.CrossRefGoogle ScholarPubMed
Hannuna, KY, Putignani, L, Silvestri, E, et al. Incidental endometrial adenocarcinoma in early pregnancy: a case report and review of the literature. Int J Gynecol Cancer. 2009 Dec;19(9):1580–4.Google ScholarPubMed
Lee, YY, Roberts, CL, Dobbins, T, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. BJOG. 2012 Dec;119(13):1572–82.Google Scholar
Parazzini, F, Franchi, M, Tavani, A, Negri, E, Peccatori, FA. Frequency of pregnancy related cancer: a population based linkage study in Lombardy, Italy. Int J Gynecol Cancer. 2017 Mar;27(3):613–19.Google Scholar
Matsuo, K, Whitman, SA, Blake, EA, et al. Feto-maternal outcome of pregnancy complicated by vulvar cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:216–23.CrossRefGoogle ScholarPubMed
Soo-Hoo, S, Luesley, D. Vulval and vaginal cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016 May;33:73–8.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×